Technical Analysis for CRRTF - Crescita Therapeutics Inc.

Grade Last Price % Change Price Change
grade C 0.6066 -2.96% -0.0185
CRRTF closed down 2.96 percent on Tuesday, August 20, 2019, on 5.24 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical CRRTF trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Volume Surge Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
BB Squeeze Ended Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%

Older signals for CRRTF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases, and their symptoms in Canada, Europe, the United States, and internationally. It owns various proprietary drug delivery platforms, including DuraPeel and MMPE that support the development of patented formulations, which facilitate the delivery of active drugs into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; Flexicaine, an anesthetic formulation of lidocaine and tetracaine for the topical treatment of pain conditions; MiCal 1 that is in Phase II clinical trial for the treatment of moderate to severe plaque psoriasis; and MiCal 2, which is in preclinical stage to treat a dermatological skin condition. Its non-prescription skincare products comprise skincare products for aging, acne, rosacea, pigmentation, dehydration, and sensitivity under the Laboratoire Dr Renaud brand; a line of cosmeceutical products for anti-aging medical procedures under the Pro-Derm brand; anti-aging skincare products to consumers of 35 years of age and over under the Premiology brand; a line of products to target and treat various skincare concerns under the Alyria brand; and a range of skincare products for hydration, sun care, atopic dermatitis, baby skin, acne, women's health, and sun damage repair under the ISDIN brand. The company also offers contract manufacturing services. Crescita Therapeutics Inc. has a collaboration agreement with Tetra Natural Health to develop Tetra's dermatology portfolio using the company's transdermal delivery technologies, multiplexed molecular penetration enhancer and DuraPeel. The company was incorporated in 2016 and is headquartered in Laval, Canada.
Medicine RTT Health Sciences Pain Diseases Pharmacology Skin Care Drug Delivery Atopic Dermatitis Contract Manufacturing Services Acne Topical Medication Skincare Products Dermatology Ointments Cosmeceutical Products Prescription Products Rosacea
Is CRRTF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.4511
52 Week Low 0.2997
Average Volume 9,547
200-Day Moving Average 0.6264
50-Day Moving Average 0.6254
20-Day Moving Average 0.7655
10-Day Moving Average 0.723
Average True Range 0.0378
ADX 29.65
+DI 45.7137
-DI 38.3686
Chandelier Exit (Long, 3 ATRs ) 0.7956
Chandelier Exit (Short, 3 ATRs ) 0.7194
Upper Bollinger Band 0.9048
Lower Bollinger Band 0.6262
Percent B (%b) -0.07
BandWidth 36.394513
MACD Line 0.0031
MACD Signal Line 0.0354
MACD Histogram -0.0323
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.6126
Resistance 3 (R3) 0.6131 0.6115 0.6116
Resistance 2 (R2) 0.6115 0.6100 0.6113 0.6113
Resistance 1 (R1) 0.6091 0.6091 0.6103 0.6086 0.6109
Pivot Point 0.6075 0.6075 0.6082 0.6073 0.6075
Support 1 (S1) 0.6051 0.6060 0.6063 0.6046 0.6023
Support 2 (S2) 0.6035 0.6051 0.6033 0.6019
Support 3 (S3) 0.6011 0.6035 0.6016
Support 4 (S4) 0.6006